Sandoz obtains FDA nod for first Tysabri biosimilarTyruko is the first biosimilar to Tysabri injection for the treatment of adults with relapsing forms of multiple sclerosis. ANI obtains FDA OK for generic DivigelGeneric Divigel is indicated for the treatment of moderate to severe hot flashes due to menopause. Camber launches generic Zetia Ezetimibe tablets are an inhibitor of intestinal cholesterol (and related phytosterol) absorption indicated as an adjunct to diet. Mallinckrodt to file for Chapter 11 bankruptcy again Mallinckrodt expects to complete the contemplated prepackaged Chapter 11 process in the fourth quarter of 2023. CVS Health launches Cordavis As its first product, Cordavis has contracted with Sandoz to commercialize and bring to market Hyrimoz, a biosimilar for Humira. Rising Pharmaceuticals launches Edetate calcium disodium injection Edetate calcium disodium injection is prescribed to reduce blood lead levels in both pediatric and adult populations. Teva to pay $225M, Glenmark to pay $30M to settle price fixing charges Generic drug makers Teva and Glenmark have agreed to divest their generic Pravachol business. Organon achieves national formulary access for Hadlima Hadlima is a tumor necrosis factor blocker indicated for patients with a variety of conditions. GRx+Bosims 2023 to feature FDA Commissioner Robert Califf FDA Commissioner Robert Califf will be the keynote FDA speaker during a “Fireside Chat” at GRx+Bosims 2023, which will be held Oct. 2-4. Upsher-Smith debuts generic Apriso Apriso is indicated for the maintenance of remission of ulcerative colitis in adults. First Previous 58 59 60 61 62 Next Last
